A Covid-19 spike like the one in China is unlikely in the US, experts say. Here’s why | CNN

CEID Faculty Dr. David Hamer shares insights on the Omicron BA.2 subvariant:

“…’The [BA.2] subvariant of Omicron is not an entire leap ahead of Omicron, whereas Omicron was really quite different than Delta,’ said Dr. Davidson Hammer, a professor of global health and medicine at Boston University. ‘I think that there are a lot of people, at least the United States, that have had Omicron, and there’s growing evidence that they’re close enough in terms of their immunologic profile that if you’ve had 1, you’re unlikely to get 2.’

In other words, there’s a more limited pool of people who might become infected in the US than in China.”

Read the full article here.